Will Canada use Russian and Chinese vaccines against COVID-19?
The skepticism has been replaced by confirmed results, but it doesn't seem to be enough.
A new study by the Lancet found that Russia's Satellite V vaccine, which was initially met with skepticism in the West, has an efficacy rate of nearly 92%, almost on par with Pfizer and Moderna, which are 95% effective.
Last week, Russia signed a deal to produce Satellite V in Italy. It was a first for the European Union, so EU regulators are studying whether to allow distribution of the vaccine.
Meanwhile, vaccines from Sinopharm and Sinovac, two Chinese companies, have received widespread approval in the Middle East and Latin America.
Despite the growing popularity of these drugs, there is no indication that any of these vaccines are on the radar of Canadian health authorities.
Epidemiologist Raivat Deonandan says Russia's Satellite V was initially met with skepticism because of a combination of politics and concerns about the quality of raw data provided by Russian scientists.
The full article is only available to members of the Immigrant.Today community. Log in to your account to read it for free.
